DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,267,000 | -7.3% | 11,274 | -0.7% | 0.43% | -29.0% |
| Q3 2020 | $2,446,000 | +20.6% | 11,356 | -1.0% | 0.61% | +11.8% |
| Q2 2020 | $2,029,000 | +25.9% | 11,474 | -1.3% | 0.54% | +2.1% |
| Q1 2020 | $1,612,000 | -9.1% | 11,630 | +0.7% | 0.53% | +17.5% |
| Q4 2019 | $1,774,000 | +20.2% | 11,548 | +13.1% | 0.45% | +9.7% |
| Q3 2019 | $1,476,000 | +0.5% | 10,206 | -0.5% | 0.41% | +0.7% |
| Q2 2019 | $1,468,000 | +7.9% | 10,256 | -0.3% | 0.41% | +6.0% |
| Q1 2019 | $1,360,000 | +27.1% | 10,284 | -0.7% | 0.39% | +7.5% |
| Q4 2018 | $1,070,000 | -5.0% | 10,356 | 0.0% | 0.36% | +5.0% |
| Q3 2018 | $1,126,000 | +12.4% | 10,356 | +2.2% | 0.34% | +8.9% |
| Q2 2018 | $1,002,000 | -99.9% | 10,130 | 0.0% | 0.31% | -2.2% |
| Q1 2018 | $991,732,000 | +30.6% | 10,130 | +23.8% | 0.32% | +31.6% |
| Q4 2017 | $759,178,000 | +8.2% | 8,180 | 0.0% | 0.24% | +4.7% |
| Q3 2017 | $701,598,000 | +1.6% | 8,180 | +0.0% | 0.23% | +23.3% |
| Q2 2017 | $690,226,000 | -0.1% | 8,179 | +1.3% | 0.19% | -12.9% |
| Q1 2017 | $690,572,000 | +5.9% | 8,074 | -3.6% | 0.22% | +8.5% |
| Q4 2016 | $651,834,000 | -46.5% | 8,374 | -4.6% | 0.20% | +14.9% |
| Q3 2016 | $1,218,812,000 | +61.5% | 8,774 | +17.4% | 0.17% | -23.0% |
| Q2 2016 | $754,874,000 | +6.5% | 7,474 | 0.0% | 0.23% | +5.6% |
| Q1 2016 | $708,983,000 | -4.9% | 7,474 | -6.9% | 0.21% | +0.5% |
| Q4 2015 | $745,456,000 | +9.0% | 8,026 | 0.0% | 0.21% | -0.9% |
| Q3 2015 | $683,898,000 | +2.6% | 8,026 | +3.0% | 0.22% | +14.4% |
| Q2 2015 | $666,832,000 | +2.1% | 7,792 | +1.3% | 0.19% | +1.6% |
| Q1 2015 | $652,966,000 | -0.9% | 7,692 | 0.0% | 0.18% | -1.6% |
| Q4 2014 | $659,196,000 | +8.3% | 7,692 | -4.0% | 0.19% | +7.4% |
| Q3 2014 | $608,602,000 | -0.6% | 8,012 | +3.0% | 0.18% | -13.4% |
| Q2 2014 | $612,204,000 | +3.6% | 7,776 | -1.3% | 0.20% | -1.0% |
| Q1 2014 | $590,925,000 | +97091.6% | 7,879 | 0.0% | 0.20% | -1.9% |
| Q4 2013 | $608,000 | – | 7,879 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |